Farms.com Home   Ag Industry News

Final chance for 2022 USDA relief funds

Apply by August 14, 2024, for USDA’s emergency relief program

By Farms.com

The U.S. Department of Agriculture (USDA) reminds farmers of the approaching deadline to apply for the Emergency Relief Program (ERP) to mitigate losses from 2022’s natural disasters.

The deadline to submit applications is August 14, 2024, with the Farm Service Agency (FSA) having opened the application window in October 2023.

“Don’t delay. Gather up your documents and contact your local office to complete the application process,” advised FSA Administrator Zach Ducheneaux. He highlighted the importance for those affected by disasters like wildfires, hurricanes, and other extreme weather events to seek the available support.

The ERP 2022 is part of the broader Disaster Relief Supplemental Appropriations Act, through which Congress has provided $3.2 billion to aid in covering an estimated $10 billion in crop and other agricultural losses.

The program specifically addresses losses to crops, trees, bushes, and vines from various qualifying natural disasters occurred in 2022.

This initiative is part of the USDA's efforts to support recovery in the agricultural sector, ensuring farmers can continue operations and contribute to the food supply chain despite the setbacks from natural calamities.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.